查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1874587

全球細胞分散市場

Cell Dissociation
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球細胞分離市場預計2030年將達到9.604億美元

全球細胞分離市場規模在2024年估計為4.959億美元，預計到2030年將達到9.604億美元，在分析期（2024-2030年）內複合年成長率（CAGR）為11.6%。本報告分析的細分市場之一—酵素分離產品，預計將以12.6%的複合年成長率成長，並在分析期間結束時達到5.069億美元。非酵素分離產品細分市場預計在分析期間內將以11.1%的複合年成長率成長。

美國市場規模估計為1.367億美元，而中國市場預計將以11.1%的複合年成長率成長。

預計到2024年，美國細胞分離市場規模將達到1.367億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到1.487億美元，在2024年至2030年的分析期內，複合年成長率（CAGR）將達到11.1%。其他值得關注的區域市場包括日本和加拿大，預計在分析期內，這兩個市場的複合年成長率將分別達到10.3%和9.6%。在歐洲，德國的複合年成長率預計將達到約8.3%。

全球細胞分離市場—關鍵趨勢與促進因素概述

細胞分散技術如何影響現代生物醫學研究？

細胞分散是生物醫學研究和治療開發中的關鍵步驟，它使研究人員能夠將貼壁細胞從培養環境中分離出來，或將組織分散成單一細胞。這項技術對於多種應用至關重要，包括細胞培養、幹細胞研究、流式細胞技術和單細胞定序。科學家可以使用胰蛋白酶和膠原蛋白酶等酵素或非酵素溶液，在不損害細胞活力或功能的情況下，溫和地將細胞從基材中釋放出來。對於後續培養、基於細胞的檢測以及涉及細胞重編程的研究而言，獲得具有活性和功能的細胞至關重要。細胞分散廣泛應用於癌症研究，其中腫瘤組織必須分散成單一細胞才能進行分子分析和藥物篩檢。它在組織工程和再生醫學中也至關重要，在這些領域中，需要分離特定類型的細胞來開發支架和人工組織。技術和試劑的進步使細胞分散更加高效，從而在最大限度地減少細胞損傷的同時，提高了活細胞的產量。這個過程的重要性涵蓋了廣泛的生物學研究，使其成為基礎科學和應用醫學研究的基本工具。

為什麼細胞分散對於單細胞分析和治療方法開發至關重要？

細胞解離在單細胞分析中發揮至關重要的作用。單細胞分析是一個新興的生物醫學研究領域，旨在揭示組織內的細胞多樣性。諸如RNA定序和蛋白質組學等單細胞技術需要將組織分解成單一細胞，以分析特定細胞群內細胞的遺傳和表現型變異。這在癌症研究中尤其重要，因為了解腫瘤多樣性可以為疾病進展和治療抗藥性提供重要的見解。在免疫學中，細胞分散可以分離特定的免疫細胞群，用於深入的功能研究和藥物測試。此外，在細胞治療方法（包括CAR-T細胞療法和幹細胞移植）的開發中，分散過程可確保從組織切片檢查或培養系統中獲得足夠數量的活細胞用於治療。分離通訊協定必須能夠維持細胞功能，這一點至關重要，因為在此過程中對細胞膜或受體的損傷會影響後續分析和治療效果。隨著單細胞生物學領域的不斷發展，對最佳化細胞分離技術的需求預計將會成長，這凸顯了能夠保持細胞完整性的精確而溫和的分離技術的重要性。

科技進步如何提高細胞解離的效率？

技術進步顯著提高了細胞解離方法的效率和可靠性，推動了研發和臨床應用領域的創新。新型酵素組合藥物和試劑的開發，最大限度地提高了細胞活力，同時最大限度地縮短了細胞分離所需的時間。例如，一些最新的酵素混合物能夠更有效地解離那些難以用傳統胰蛋白酶方法解離的組織，例如纖維化組織和富含膠原蛋白的樣本。除了酵素法之外，非酵素解離方法也日益普及。這些方法能夠在解離細胞的同時，最大限度地減少對細胞表面蛋白的影響，使其成為流式細胞技術和受體分析等敏感應用的理想選擇。自動化和高通量系統也改善了細胞解離，使得同時處理多個樣本並提高精確度成為可能。微流體技術和機械解離裝置為酵素法提供了替代方案，降低了酵素損傷的風險，並能夠解離更複雜的組織，例如腦組織和肝臟樣本。這些創新不僅提高了分離細胞的品質和數量，而且擴大了可有效研究的組織和應用範圍，為基於細胞的研究和臨床治療開闢了新的可能性。

哪些因素正在推動細胞分散市場的成長？

細胞分離市場的成長受多種因素驅動，包括生物技術的進步、個人化醫療的興起以及對細胞療法日益成長的需求。其中一個關鍵促進因素是藥物發現和開發中對高品質單細胞的需求不斷成長。製藥公司和研究機構依賴分離的細胞進行新藥篩檢，尤其是腫瘤學和免疫療法等領域。再生醫學中幹細胞研究的擴展也推動了對能夠維持幹細胞活力和分化潛能的最佳化細胞分離技術的需求。技術進步，例如更高效的酶促和非酶分離試劑的開發，正在推動實驗室和臨床環境中的應用，使該過程更加可靠和擴充性。基因組學和蛋白​​質組學中向單細胞分析的轉變也是一個主要促進因素，分離是分離單一細胞進行深入分子研究的關鍵步驟。消費行為，例如醫療費用支出的增加以及慢性病和癌症盛行率的上升，進一步推動了市場成長。此外，細胞分離技術在新興領域（例如3D生物列印和組織工程）的日益普及，為建構複雜的組織結構提供了對細胞群的精確控制，從而創造了新的市場擴張機會。預計這些趨勢將在未來幾年內持續推動細胞分離市場的快速成長。

部分：

產品類型（酵素分離產品、非酵素分離產品、設備和配件）、組織（結締組織、上皮組織、其他組織）、最終用途（製藥和生物技術公司、研究和學術機構、其他最終用途）

受訪公司範例

  • American Type Culture Collection（ATCC）
  • Becton, Dickinson & Company
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • HiMedia Laboratories
  • Merck KgaA
  • Miltenyi Biotec GmbH
  • PAN-Biotech GmbH
  • StemCell Technologies Inc.
  • Thermo Fisher Scientific, Inc.

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具，改變您分析市場和競爭情報的方式。

Global Industry Analysts 並沒有依賴通用的 LLM 或查詢產業專用的SLM，而是建立了一個由世界各地領域專家精心整理的內容庫，包括視訊轉錄、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

我們最新發布的報告納入了關稅對區域市場的影響，正如全球產業分析師預測的那樣，關稅將改變企業的競爭地位，而企業的競爭地位將取決於其總部所在地、製造地以及進出口（成品和OEM產品）。這種複雜多變的市場現實將透過微觀和宏觀市場動態影響競爭對手，包括銷貨成本增加、盈利下降以及供應鏈重組。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 世界其他地區

第4章 競賽

簡介目錄
Product Code: MCP10940

Global Cell Dissociation Market to Reach US$960.4 Million by 2030

The global market for Cell Dissociation estimated at US$495.9 Million in the year 2024, is expected to reach US$960.4 Million by 2030, growing at a CAGR of 11.6% over the analysis period 2024-2030. Enzymatic Dissociation Products, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$506.9 Million by the end of the analysis period. Growth in the Non-enzymatic Dissociation Products segment is estimated at 11.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$136.7 Million While China is Forecast to Grow at 11.1% CAGR

The Cell Dissociation market in the U.S. is estimated at US$136.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$148.7 Million by the year 2030 trailing a CAGR of 11.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.3% and 9.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.

Global Cell Dissociation Market - Key Trends and Drivers Summarized

How Is Cell Dissociation Shaping Modern Biomedical Research?

Cell dissociation is a critical process in biomedical research and therapeutic development, enabling researchers to separate adherent cells from their culture environment or dissociate tissues into single cells. This technique is essential for various applications, including cell culture, stem cell research, flow cytometry, and single-cell sequencing. By using enzymes such as trypsin, collagenase, or non-enzymatic solutions, scientists can gently release cells from their substrates without compromising cell viability or function. The ability to obtain viable, functional cells is paramount for studies that involve subsequent culturing, cell-based assays, or cellular reprogramming. Cell dissociation is widely used in cancer research, where tumor tissues must be dissociated into individual cells for molecular analysis or drug screening. It is also crucial in tissue engineering and regenerative medicine, where the isolation of specific cell types is required for developing scaffolds and artificial tissues. With advancements in techniques and reagents, cell dissociation has become more efficient, enabling researchers to achieve higher yields of viable cells while minimizing cell damage. The significance of this process extends across a broad range of biological research fields, making it a fundamental tool in both basic science and applied medical research.

Why Is Cell Dissociation Essential for Single-Cell Analysis and Therapeutics?

Cell dissociation plays a pivotal role in single-cell analysis, a rapidly growing field in biomedical research that seeks to understand cellular heterogeneity within tissues. Single-cell technologies, such as RNA sequencing and proteomics, require the dissociation of tissues into individual cells to analyze the genetic and phenotypic diversity of cells in a given population. This is particularly important in cancer research, where understanding tumor heterogeneity can reveal critical insights into disease progression and treatment resistance. In immunology, cell dissociation enables the isolation of specific immune cell populations for in-depth functional studies and drug testing. Furthermore, in the development of cell-based therapeutics, including CAR-T cell therapy and stem cell transplants, the dissociation process ensures that enough viable cells are obtained from tissue biopsies or culture systems for therapeutic use. Ensuring that dissociation protocols preserve cell functionality is essential, as any damage to cell membranes or receptors during the process could affect downstream analysis or therapeutic efficacy. As the field of single-cell biology continues to expand, the demand for optimized cell dissociation techniques will only increase, emphasizing the importance of precise and gentle dissociation methods to preserve cell integrity.

How Are Technological Advancements Enhancing the Efficiency of Cell Dissociation?

Technological advancements have significantly improved the efficiency and reliability of cell dissociation methods, driving innovation in both research and clinical applications. New enzymatic formulations and reagents have been developed to minimize the time required for cell detachment while maximizing cell viability. For example, some of the newer enzyme blends can dissociate more resistant tissues, such as fibrotic or heavily collagenous samples, more effectively than traditional methods like trypsinization. In addition to enzymes, non-enzymatic solutions have gained traction for their ability to dissociate cells with reduced impact on surface proteins, making them ideal for sensitive applications like flow cytometry and receptor analysis. Automation and high-throughput systems have also enhanced cell dissociation, allowing laboratories to process multiple samples simultaneously and with greater precision. Microfluidics and mechanical dissociation devices provide alternative methods to enzymatic approaches, reducing the risk of enzyme-induced damage and enabling the dissociation of more complex tissues, such as brain or liver samples. These innovations not only improve the quality and quantity of dissociated cells but also expand the range of tissues and applications that can be effectively studied, pushing the boundaries of cell-based research and clinical therapeutics.

What Is Driving the Growth in the Cell Dissociation Market?

The growth in the cell dissociation market is driven by several factors, including advancements in biotechnology, the rise of personalized medicine, and increasing demand for cell-based therapies. One of the key drivers is the growing need for high-quality single cells in drug discovery and development. Pharmaceutical companies and research institutions rely on dissociated cells to screen for new drugs, particularly in areas like oncology and immunotherapy. The expansion of stem cell research, especially in regenerative medicine, is also fueling demand for optimized cell dissociation techniques that can preserve stem cell viability and differentiation potential. Technological advancements, such as the development of more efficient enzymatic and non-enzymatic dissociation reagents, are driving adoption in laboratories and clinics, making the process more reliable and scalable. The shift toward single-cell analysis in genomics and proteomics is another major factor, as dissociation is a critical step in isolating individual cells for detailed molecular studies. Consumer behavior in the form of increased healthcare spending, along with the rising prevalence of chronic diseases and cancer, is further propelling market growth. Additionally, the increasing use of cell dissociation in emerging applications such as 3D bioprinting and tissue engineering presents new opportunities for market expansion, as these fields require precise control over cell populations for the creation of complex tissue structures. Together, these trends are expected to sustain the rapid growth of the cell dissociation market in the coming years.

SCOPE OF STUDY:

The report analyzes the Cell Dissociation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Enzymatic Dissociation Products, Non-Enzymatic Dissociation Products, Instruments & Accessories); Tissue (Connective Tissue, Epithelial Tissue, Other Tissues); End-Use (Pharma & Biotech Companies, Research & Academic Institutes, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • American Type Culture Collection (ATCC)
  • Becton, Dickinson & Company
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • HiMedia Laboratories
  • Merck KgaA
  • Miltenyi Biotec GmbH
  • PAN-Biotech GmbH
  • StemCell Technologies Inc.
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Global Economic Update
    • Cell Dissociation - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rise of Single-Cell Analysis Expands Addressable Market Opportunity
    • Increasing Use of Cell-Based Assays in Drug Discovery Spurs Market Growth
    • Advanced Enzymatic Dissociation Technologies Drive Adoption in Cancer Research
    • High-Throughput Screening Propels Demand for Automated Cell Dissociation Systems
    • Growing Application of 3D Cell Cultures Generates New Market Opportunities
    • Stem Cell Research and Therapy Drive Adoption of Optimized Cell Dissociation Protocols
    • Advancements in Microfluidic Technology Propel Innovation in Cell Isolation and Dissociation
    • Increased Focus on Immunotherapy Expands Demand for Gentle Cell Dissociation Solutions
    • Growth of Regenerative Medicine Sustains Demand for Customized Dissociation Technologies
    • Rise of Biopharmaceuticals Drives Demand for Scalable Cell Dissociation Processes
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cell Dissociation Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cell Dissociation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Cell Dissociation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Enzymatic Dissociation Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Enzymatic Dissociation Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Non-enzymatic Dissociation Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Non-enzymatic Dissociation Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Instruments & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Instruments & Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Research & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Research & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Connective Tissue by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Connective Tissue by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Epithelial Tissue by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Epithelial Tissue by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Tissues by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Other Tissues by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cell Dissociation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 22: USA Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2025 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2025 & 2030
  • CANADA
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2025 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2025 & 2030
  • JAPAN
    • Cell Dissociation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2025 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2025 & 2030
  • CHINA
    • Cell Dissociation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 40: China Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2025 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2025 & 2030
  • EUROPE
    • Cell Dissociation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Cell Dissociation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Cell Dissociation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2025 & 2030
  • FRANCE
    • Cell Dissociation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 54: France Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2025 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2025 & 2030
  • GERMANY
    • Cell Dissociation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2025 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2025 & 2030
  • ITALY
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2025 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2025 & 2030
  • UNITED KINGDOM
    • Cell Dissociation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 72: UK Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2025 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2025 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 6-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2025 & 2030
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Cell Dissociation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2025 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 6-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2025 & 2030
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2025 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World 6-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2025 & 2030
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2025 & 2030

IV. COMPETITION